SAS Output

20-AUG-2018 6:10

LYMPH ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1608-Rel/Ref FL, TGR-1202/Lenalidomide/CHOP + Ob 1 Y 1 TGR-1202 + Obinutuzumab 150 2 2 1 0 0 0 01/23/2018 286 105
        2 Lenalidomide + Obinutuzumab   1 1 1 0 0 0      
        3 CHOP + Obinutuzumab   3 3 2 1 0 0      
            6 6 4 1 0 0      
 
Yes A051301-ABC DLBCL, Auto HCT and Ibrutinib/Placebo 0 E Total Registrations   55 29 13 5 2 2 10/12/2016 166 72
            55 29 13 5 2 2      
 
    1 E Total Registrations   6 4 0 0 0 0 10/12/2016    
            6 4 0 0 0 0      
 
  EA4151-Lymph, AHCT +/-Ritux, MRD Neg 0 E Total Registrations   8 8 8 4 1 0 04/03/2018 47 17
            8 8 8 4 1 0      
 
    1 E Total Registrations   3 3 3 3 0 0 04/03/2018    
            3 3 3 3 0 0